...
首页> 外文期刊>Journal of Clinical and Diagnostic Research >Synchronous Diffuse Large B-Cell Lymphoma and Malignant Clonal Plasma Cells in Bone Marrow As Primary Presentation: A Diagnostic and Therapeutic Challenge
【24h】

Synchronous Diffuse Large B-Cell Lymphoma and Malignant Clonal Plasma Cells in Bone Marrow As Primary Presentation: A Diagnostic and Therapeutic Challenge

机译:同步弥漫性大B细胞淋巴瘤和骨髓中的恶性克隆浆细胞作为主要表现:诊断和治疗挑战

获取原文

摘要

Coexistence of Diffuse Large B-Cell Lymphoma (DLBCL) with other morphologically and phenotypically distinct lymphoid neoplasm although unusual, has been reported in literature. The most common lymphoid neoplasms associated with DLBCL are Hodgkin?s lymphoma, mantle cell lymphoma and marginal zone lymphoma. However, they have been reported predominantly in the sites other than the bone marrow. Rarely, DLBCL associated with paraproteinemia of IgM type, result of monoclonal plasma cell proliferation, has also been reported in literature. There is either an associated increase in the free light chain levels or disruption in the normal kappa: lambda ratio. However, co-existence of DLBCL with malignant non secretory clonal plasma cells, diagnosed primarily in the bone marrow has not been reported in the literature.
机译:文献报道了弥漫性大B细胞淋巴瘤(DLBCL)与其他形态和表型不同的淋巴样肿瘤共存,尽管并不常见。与DLBCL相关的最常见的淋巴瘤是霍奇金淋巴瘤,套细胞淋巴瘤和边缘区淋巴瘤。但是,据报道主要在骨髓以外的地方。很少有文献报道DLBCL与IgM型副蛋白血症有关,这是单克隆浆细胞增殖的结果。游离轻链水平增加或正常kappa:lambda比值中断。然而,文献中尚未报道DLBCL与主要在骨髓中诊断出的恶性非分泌性克隆浆细胞共存。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号